The HARMONY Alliance was established in January 2017. This website offers a glance of who we are, what we offer and how we work.
The HARMONY Alliance is a European Network of Excellence for Big Data in Hematology, consisting of 53 partners. Partners are representatives from Medical Centers, Universities, Patient Organizations, Medicines Authorities, Pharmaceutical Companies, Information and Communications Technology Companies and the European Hematology Association. Click here for an overview of all HARMONY Partners.
What is meant by Big Data in healthcare? / How is Big Data in healthcare collected and analysed? / Who can use Big Data in healthcare and how? / What are the benefits of using Big Data for patients? / What are health outcomes? / Why is value-based and outcomes-focused healthcare important? Find the answers here >>
"HARMONY helps to improve the prognosis and outcome of patients with hematological cancers, and is driven by knowledge derived from the combination and analysis of complex data. However, this will only make a difference to real patients if the evidence, findings and outcomes of the project are meaningful and relevant not only to patients, but also to medicines authorities, health technology assessment bodies, payers and policy makers.
Through its Stakeholder Forum, HARMONY will collect input from patient organizations and all other stakeholders to discuss needs, gaps, opportunities and barriers, thus informing the implementation of the project across work packages. HARMONY will also support the decision-making process of regulators, HTA bodies and payers by assessing and developing hematology-specific evidence frameworks and clinical value frameworks that will help to quantify the therapeutic value of innovative technologies."
Big Data in Patient Care: What does it mean? Listen to the video interview with Egge van der Poel, Associate Dean Permanent Education for Professionals Jheronimus Academy of Data Science; Erasmus MC Clinical Data Scientist, The Netherlands.
Egge van der Poel was invited by the HARMONY Alliance to provide an inspirational presentation during the HARMONY Interactive Session at the 1st European Alliance for Personalised Medicine Congress 2017, on 28 November 2017 in Belfast, Ireland.
Tamás Bereczky, HARMONY Partner, Leukanet explains patient involvement in the HARMONY Alliance. Tamás Bereczky, who is also involved in the European Patients’ Academy for Therapeutic Innovation, was also interviewed at EAPM2017 in Belfast.
HARMONY Partner and Co-Chair Guillermo Sanz, Head of Clinical Hematology Section, Fundación para la Investigación del Hospital Universitario La Fe de la Comunidad Valenciana (HULAFE), Spain, explains the scientific impact the HARMONY Alliance is aiming for.
Do you have suggestions as regards topics on this page?
Please share your ideas! Contact Ellen de Waal, HARMONY Communication Manager.